Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medpace Holdings Inc (MEDP) vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF (QDTY) Price & Performance

Medpace Holdings IncTrade
YieldMax Nasdaq 100 0DTE Covered Call Strategy ETFTrade

Price performance (Past 24H)

Key statistics

Medpace Holdings Inc vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF — how do they compare? Medpace Holdings Inc trades at $530.31 (market cap $15.08B), while YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF trades at $40.16. The key difference: Medpace Holdings Inc is trading nearer its 52-week high, YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals.

MEDPQDTY
Market Cap
$15.08B
Sector
TechnologyIncome / Options Overlay
52-Week High
$620.59$46.71
52-Week Low
$308.88$36.57
Enterprise Value
$14.55B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medpace Holdings Inc

MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.

MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.

YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF

QDTY trades at $39.53 with minimal daily movement (+0.15%). The stock demonstrates consistent dividend distributions with weekly payouts ranging from $0.22 to $0.32 per share throughout 2026. Technical indicators show stable price action while fundamental metrics remain undisclosed in available data. Recent corporate actions focus exclusively on dividend distributions with no significant business developments reported.

The outlook for QDTY appears income-focused given the regular dividend schedule, though fundamental analysis is limited by missing financial ratios. Key risks include dependency on dividend sustainability and potential market volatility. Investment appeal centers on yield generation rather than growth prospects, requiring careful monitoring of underlying financial health.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP

About YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF

QDTY is an actively managed ETF that employs a synthetic covered call strategy on the Nasdaq-100 Index using zero-days-to-expiration (0DTE) options. It aims to generate high weekly income by selling daily call options, providing limited participation in the index's upside while remaining fully exposed to its downside risk.

Read more on QDTY